Northwestern Mutual Wealth Management Co. lowered its position in shares of UnitedHealth Group Inc. (NYSE:UNH) by 35.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 71,658 shares of the healthcare conglomerate’s stock after selling 39,132 shares during the period. Northwestern Mutual Wealth Management Co.’s holdings in UnitedHealth Group were worth $10,117,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of UNH. Van Hulzen Asset Management LLC acquired a new position in UnitedHealth Group during the second quarter worth approximately $104,000. Archford Capital Strategies LLC boosted its stake in UnitedHealth Group by 669.2% in the second quarter. Archford Capital Strategies LLC now owns 800 shares of the healthcare conglomerate’s stock worth $113,000 after buying an additional 696 shares in the last quarter. Hanson McClain Inc. boosted its stake in UnitedHealth Group by 0.4% in the second quarter. Hanson McClain Inc. now owns 895 shares of the healthcare conglomerate’s stock worth $126,000 after buying an additional 4 shares in the last quarter. Howe & Rusling Inc. boosted its stake in UnitedHealth Group by 4.5% in the second quarter. Howe & Rusling Inc. now owns 920 shares of the healthcare conglomerate’s stock worth $130,000 after buying an additional 40 shares in the last quarter. Finally, Parkside Financial Bank & Trust boosted its stake in UnitedHealth Group by 31.4% in the second quarter. Parkside Financial Bank & Trust now owns 996 shares of the healthcare conglomerate’s stock worth $140,000 after buying an additional 238 shares in the last quarter. 86.32% of the stock is currently owned by institutional investors and hedge funds.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

UnitedHealth Group Inc. (NYSE:UNH) opened at 146.42 on Monday. The stock’s 50 day moving average is $140.09 and its 200 day moving average is $138.33. The firm has a market cap of $139.36 billion, a PE ratio of 21.63 and a beta of 0.63. UnitedHealth Group Inc. has a 12 month low of $107.51 and a 12 month high of $147.50.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 18th. The healthcare conglomerate reported $2.17 earnings per share for the quarter, beating analysts’ consensus estimates of $2.08 by $0.09. UnitedHealth Group had a return on equity of 19.92% and a net margin of 3.62%. The business earned $46.30 billion during the quarter, compared to analysts’ expectations of $46.09 billion. During the same quarter last year, the business posted $1.77 earnings per share. The business’s revenue for the quarter was up 11.6% on a year-over-year basis. On average, equities analysts forecast that UnitedHealth Group Inc. will post $8.01 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 13th. Investors of record on Friday, December 2nd will be given a dividend of $0.625 per share. This represents a $2.50 dividend on an annualized basis and a yield of 1.71%. The ex-dividend date of this dividend is Wednesday, November 30th. UnitedHealth Group’s dividend payout ratio is presently 36.93%.

A number of analysts have recently weighed in on UNH shares. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $160.00 price target on the stock in a report on Friday, July 22nd. Argus upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $170.00 price target on the stock in a report on Friday, July 22nd. Citigroup Inc. raised their price target on shares of UnitedHealth Group from $148.00 to $164.00 and gave the company a “buy” rating in a report on Wednesday, July 20th. Mizuho raised their price target on shares of UnitedHealth Group from $156.00 to $160.00 and gave the company a “buy” rating in a report on Tuesday, July 19th. Finally, Credit Suisse Group AG restated a “buy” rating and issued a $155.00 price target (up from $148.00) on shares of UnitedHealth Group in a report on Wednesday, July 20th. Three research analysts have rated the stock with a hold rating, twenty-three have assigned a buy rating and one has issued a strong buy rating to the company. The company has an average rating of “Buy” and an average price target of $155.84.

In related news, Director Kenneth Irwin Shine sold 325 shares of UnitedHealth Group stock in a transaction dated Friday, October 21st. The stock was sold at an average price of $144.99, for a total transaction of $47,121.75. Following the completion of the sale, the director now owns 28,613 shares in the company, valued at approximately $4,148,598.87. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Richard T. Burke sold 40,000 shares of UnitedHealth Group stock in a transaction dated Wednesday, September 7th. The stock was sold at an average price of $135.31, for a total value of $5,412,400.00. Following the sale, the director now owns 2,003,550 shares of the company’s stock, valued at approximately $271,100,350.50. The disclosure for this sale can be found here. Corporate insiders own 1.65% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

5 Day Chart for NYSE:UNH

Receive News & Stock Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related stocks with our FREE daily email newsletter.